Historical record - last NADAC effective date: 6/29/2022
Product Information
MUCINEX FAST-MAX COLD-FLU-THRT is a brand product labeled by RB Health (US) LLC, priced at $0.7369 per EA under NDC 72854012716. Its NADAC has been published 51 times since Jun 29, 2022.
The High Outlier badge above means this manufacturer's average price in the Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
MUCINEX FAST-MAX COLD-FLU-THRT
Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine HydrochlorideStrength
325; 10; 200; 5 mg/1; mg/1; mg/1; mg/1
Manufacturer
RB Health (US) LLCNDC
72854012716
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
6/29/2022
Active Ingredients
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
7/26/2021
Pharmacological Classes
Price Statistics
The NADAC for MUCINEX FAST-MAX COLD-FLU-THRT has been published 51 times since Jun 29, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7369 per EA |
|---|---|
| All-time high | $0.7369 (Jun 14, 2023) |
| All-time low | $0.7369 (Jun 29, 2022) |
| Median price | $0.7369 |
| Average price | $0.7369 |
| Largest weekly change | 0.0% (Jul 6, 2022) |
| Weeks tracked | 51 |
| Tracking since | Jun 29, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Jun 14, 2023 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, and Phenylephrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MUCINEX FAST-MAX COLD-FLU-THRT?
The current National Average Drug Acquisition Cost (NADAC) for MUCINEX FAST-MAX COLD-FLU-THRT, manufactured by RB Health (US) LLC, is $0.7369 per EA (NDC 72854012716), effective Jun 14, 2023.
How has the price of MUCINEX FAST-MAX COLD-FLU-THRT changed over time?
Over the history we have for it, the NADAC for MUCINEX FAST-MAX COLD-FLU-THRT has held within roughly two percent of its current level. It has been tracked across 51 weekly CMS publications since Jun 29, 2022.
What are the highest and lowest recorded NADAC prices for MUCINEX FAST-MAX COLD-FLU-THRT?
Since Jun 29, 2022, the NADAC for MUCINEX FAST-MAX COLD-FLU-THRT has ranged from a low of $0.7369 (Jun 29, 2022) to a high of $0.7369 (Jun 14, 2023), with a median of $0.7369 per EA.
Are there cheaper alternatives to MUCINEX FAST-MAX COLD-FLU-THRT?
No other NADAC-published product currently shares the active ingredient and strength of MUCINEX FAST-MAX COLD-FLU-THRT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures MUCINEX FAST-MAX COLD-FLU-THRT?
MUCINEX FAST-MAX COLD-FLU-THRT (NDC 72854012716) is labeled by RB Health (US) LLC, and CMS classifies it as a brand product.